Advertisement
Advertisement
NMRA
Neumora Therapeutics, Inc. Common Stock
1.38
USDSponsored
+0.04
+3.38%
Sep 02, 15:58 UTC -4
Open
NMRA Earnings Reports
Positive Surprise Ratio
NMRA beat 7 of 12 last estimates.
58%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Neumora Therapeutics, Inc. Common Stock earnings per share and revenue
On Aug 14, 2026, NMRA reported earnings of -0.23 USD per share (EPS) for Q2 26, beating the estimate of -0.24 USD, resulting in a 6.05% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.51% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-Surprise
-
Anavex Life Sciences
Report Date
Aug 25, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-Actual
-$0.35
Surprise
-
Chemomab Therapeutics Ltd. - ADR
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.24
Surprise
-56.86%
FAQ
What were Neumora Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Neumora Therapeutics, Inc. Common Stock reported EPS of -$0.23, beating estimates by 6.05%, and revenue of $0.00, 0% as expectations.
How did the market react to Neumora Therapeutics, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -7.51%, changed from $1.73 before the earnings release to $1.60 the day after.
When is Neumora Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Neumora Therapeutics, Inc. Common Stock's next earnings report?
Based on --
analysts, Neumora Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement